StockpollyBeta
Get App
Delisting riskPopularity #5,126
TRAW · NASDAQ · Biotechnology

Traws Pharma (TRAW)

Develops oral antivirals for influenza and COVID-19.

$0.5088
vs last close+0.01 (+1.80%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions40.63%6.16M shares
34 holders · as of Jun 30, 2026
Insiders4.61%698.9K shares
10 holders · as of Apr 8, 2026
Other54.76%8.30M shares
remainder

15.15M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Orbimed Advisors LLCInstitution
7.94%1.20Mas of Jun 30, 2026
Perceptive Advisors LLCInstitution
6.47%979,815filed May 15, 2026
Ally Bridge Group (NY) LLCInstitution
5.19%786,236as of Jun 30, 2026
Adage Capital Partners GP, L.L.C.Institution
4.82%730,000as of Jun 30, 2026
Adar1 Capital Management, LLCInstitution
3.95%597,729as of Jun 30, 2026
LYNX1 Capital Management LPInstitution
3.69%559,470as of Jun 30, 2026
Ikarian Capital, LLCInstitution
3.16%478,142as of Jun 30, 2026
Sphera Funds Management Ltd.Institution
2.63%398,486as of Jun 30, 2026
Vanguard Capital Management LLCInstitution
2.18%330,049as of Jun 30, 2026
Jane Street Group, LLCInstitution
1.43%216,006as of Jun 30, 2026
Iain D. DukesInsiderdirector, officer: Chief Executive Officer
1.13%171,130filed Dec 16, 2025
Alyeska Investment Group, L.P.Institution
1.08%164,376as of Jun 30, 2026
Nikolay SavchukInsiderdirector, officer: Chief Operating Officer
0.99%150,606filed Dec 16, 2025
Boothbay Fund Management, LLCInstitution
0.88%133,936as of Jun 30, 2026
Charles David PauzaInsiderofficer: Chief Science Officer Virology
0.77%115,971filed Dec 16, 2025
Robert RedfieldInsiderofficer: Chief Medical Officer
0.75%113,919filed Dec 16, 2025
Geode Capital Management, LLCInstitution
0.74%111,365as of Jun 30, 2026
Werner CautreelsInsiderdirector
0.72%109,222filed Dec 16, 2025
HRT Financial LPInstitution
0.60%91,220as of Jun 30, 2026
Kynam Capital Management, LPInstitution
0.56%84,400as of Jun 30, 2026
Dauntless Investment Group, LLCInstitution
0.53%80,574as of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution
0.36%54,511as of Jun 30, 2026
Northern Trust CorpInstitution
0.25%37,454as of Jun 30, 2026
State Street CorpInstitution
0.17%25,802as of Jun 30, 2026
XTX Topco LtdInstitution
0.12%18,092as of Jun 30, 2026

13F, as of Jun 30, 2026

34 holders · 6.16M shares · 13 new positions · 22 increased · 8 reduced · 6 closed

HolderShares% outstandingChg q/qFiled
Orbimed Advisors LLC1.20M7.94%+597.7KAug 14, 2026
Ally Bridge Group (NY) LLC786.2K5.19%+786.2KnewAug 14, 2026
Adage Capital Partners GP, L.L.C.730.0K4.82%0Aug 14, 2026
Adar1 Capital Management, LLC597.7K3.95%+443.6KAug 14, 2026
LYNX1 Capital Management LP559.5K3.69%+544.4KAug 13, 2026
Ikarian Capital, LLC478.1K3.16%−200.0KAug 14, 2026
Sphera Funds Management Ltd.398.5K2.63%+398.5KnewAug 14, 2026
Vanguard Capital Management LLC330.0K2.18%+274.9KAug 13, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
OrbiMed Advisors LLCincl. OrbiMed Capital GP VIII LLC19.90%602.0K13DSep 23, 2024
Ikarian Capital, LLC9.99%812.5K13GFeb 17, 2026
Sirenia Capital Management LP9.90%6.57M13GAug 14, 2026
Alyeska Investment Group, L.P.9.90%302.3K13GFeb 14, 2025
Adage Capital Management, L.P.9.14%730.0K13GFeb 12, 2026
Chernett Jorey6.80%543.3K13GJan 16, 2026
Squadron Master Fund LP6.40%511.7K13GMay 15, 2026
Perceptive Advisors LLC6.10%979.8K13GMay 15, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 16, 2026
Orbimed Advisors LLC10 percent owner
Purchase · 4 lots3,586,374$1.674,191,895

House and Senate disclosures

Not reported.